The use of transgenic and knock-out mice in the investigation of ocular surface cell biology

Ocular Surface

Volumn 1, Issue 1, 2003, Pages 5-19

  Kao, Winston W Y ^a   Liu, Chia Yang ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Doxycycline induction; Dry eye; Eye development; Gene targeting; Gene therapy; Genetics; Growth factors; Transgenic mouse

Indexed keywords

BIGLYCAN; COLLAGEN; CRE RECOMBINASE; CYTOKINE; DECORIN; DOXYCYCLINE; FIBROMODULIN; GROWTH FACTOR; HOMEODOMAIN PROTEIN; INTEGRIN; KERATIN; KERATOCAN; LUMICAN; MITOGEN ACTIVATED PROTEIN KINASE; PROTEOGLYCAN; SCLEROPROTEIN; TETRACYCLINE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PAX6; TRANSCRIPTION FACTOR PITX2; TRANSFORMING GROWTH FACTOR;

ANIMAL MODEL; ANIRIDIA; CONGENITAL DISORDER; CORNEA; CORNEA CELL; CORNEA DISEASE; CYTOLOGY; DISEASE MODEL; DNA MODIFICATION; EMBRYO DEATH; EYE DISEASE; GENE EXPRESSION; GENE EXPRESSION SYSTEM; GENE FUNCTION; GENE INDUCTION; GENE LOSS; GENE MUTATION; GENE OVEREXPRESSION; GENE TARGETING; GENE THERAPY; HOMEOSTASIS; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PROMOTER REGION; REPORTER GENE; REVIEW; STEM CELL TRANSPLANTATION; TISSUE SPECIFICITY; TRANSCRIPTION INITIATION; TRANSGENE; TRANSGENIC MOUSE; TRANSGENICS; WOUND HEALING;

EID: 9644291285     PISSN: 15420124     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1542-0124(12)70003-4     Document Type: Article

References (133)

1. Camper SA. Research application of transgenic mice. Biotechniques 1987;5:638-50
2. Camper SA, Saunders TL, Kendall SK, et al. Implementing transgenic and embryonic stem cell technology to study gene expression, cell-cell interactions and gene function (Review). Biol Reprod 1995;52:246-57
3. Windle JJ, Weiner RI, Mellon PL. Cell lines of the pituitary gonadotrope lineage derived by targeted oncogenesis in transgenic mice. Mol Endocrinol 1990;4:597-603
4. Hammer RE, Brinster RL, Rosenfeld MG, et al. Expression of human growth hormone-releasing factor in transgenic mice results in increased somatic growth. Nature 1985;315:413-6
5. Glasser SW, Korfhagen TR, Wert SE, Whitsett JA. Transgenic models for study of pulmonary development and disease (Review). Am J Physiol 1994;267:L489-97
6. Paigen B, Plump AS, Rubin EM. The mouse as a model for human cardiovascular disease and hyperlipidemia (Review). Curr Opin Lipidol 1994;5:258-64.
7. Boyd AL, Samid D: Review: molecular biology of transgenic animals (Review). J Anim Sci 1993;71 Suppl 3:1-9
8. Lloyd C, Yu GC, Cheng J, et al. The basal keratin network of stratified squamous epithelia: defining K15 function in the absence of K14. J Cell Biol 1995;129:1329-44
9. Carroll JM, Luetteke NC, Lee DC, Watt FM. Role of integrins in mouse eyelid development: studies in normal embryos and embryos in which there is a failure of eyelid fusion. Mech Dev 1998;78:37-45
10. Go C, He W, Zhong L, et al. Aberrant cell cycle progression contributes to the early-stage accelerated carcinogenesis in transgenic epidermis expressing the dominant negative TGFbetaRII. Oncogene 2000;19:3623-31
11. Ying S, Jansen HT, Lehman MN, et al. Retinal degeneration in cone photoreceptor cell-ablated transgenic mice. Mol Vis 2000;6:101-8
12. Ross SR, Graves RA, Spiegelman BM. Targeted expression of a toxin gene to adipose tissue: transgenic mice resistant to obesity. Genes Dev 1993;7:1318-24
13. Breitman ML, Rombola H, Maxwell IH, et al. Genetic ablation in transgenic mice with an attenuated diphtheria toxin A gene. Mol Cell Biol 1990;10:474-9
14. St Onge L, Furth PA, Gruss P. Temporal control of the Cre recombinase in transgenic mice by a tetracycline responsive promoter. Nucleic Acids Res 1996;24:3875-7
15. Furth PA, St Onge L, Boger H, et al. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA 1994;91:9302-6
16. Breitman ML, Bryce DM, Giddens E, et al. Analysis of lens cell fate and eye morphogenesis in transgenic mice ablated for cells of the lens lineage. Development 1989;106:457-63
17. Landel CP, Zhao J, Bok D, Evans GA. Lens-specific expression of recombinant ricin induces developmental defects in the eyes of transgenic mice. Genes Dev 1988;2:1168-78
18. Breitman ML, Clapoff S, Rossant J, et al. Genetic ablation: targeted expression of a toxin gene causes microphthalmia in transgenic mice. Science 1987;238:1563-5
19. Doetschman T, Gregg RG, Maeda N, et al. Targetted correction of a mutant HPRT gene in mouse embryonic stem cells. Nature 1987;330:576-8
20. Koller BH, Hagemann LJ, Doetschman T, et al. Germ-line transmission of a planned alteration made in a hypoxanthine phosphoribosyltransferase gene by homologous recombination in embryonic stem cells. Proc Natl Acad Sci USA 1989;86:8927-31
21. Hanks M, Wurst W, Anson-Cartwright L, et al. Rescue of the En-1 mutant phenotype by replacement of En-1 with En-2. Science 1995;269:679-82
22. Govindarajan V, Overbeek PA. Secreted FGFR3, but not FGFR1, inhibits lens fiber differentiation. Development 2001;128:1617-27
23. Trelstad RL, Hayashi A, Hayashi K, Donahoe PK. The epithelial-mesenchymal interface of the male rate Mullerian duct: loss of basement membrane integrity and ductal regression. Dev Bio 1982;92:27-40
24. Spring K, Cross S, Li C, et al. Atm knock-in mice harboring an in-frame deletion corresponding to the human ATM 7636del9 common mutation exhibit a variant phenotype. Cancer Res 2001;61:4561-8
25. Doetschman T. Interpretation of phenotype in genetically engineered mice. Lab Anim Sci 1999;49:137-43
26. Liu C, Arar H, Kao C, Kao WW. Identification of a 3.2 kb 5′-flanking region of the murine keratocan gene that directs beta-galactosidase expression in the adult corneal stroma of transgenic mice. Gene 2000;250:85-96
27. Liu CY, Shiraishi A, Kao CW, et al. The cloning of mouse keratocan cDNA and genomic DNA and the characterization of its expression during eye development. J Biol Chem 1998;273:22584-8
28. Liu CY, Zhu G, Westerhausen-Larson A, et al. Cornea-specific expression of K12 keratin during mouse development. Curr Eye Res 1993;12:963-74
29. Shiraishi A, Converse RL, Liu CY, et al. Identification of the cornea-specific keratin 12 promoter by in vivo particle-mediated gene transfer. Invest Ophthalmol Vis Sci 1998;39:2554-61
30. Zhu G, Ishizaki M, Haseba T, et al. Expression of K12 keratin in alkali-burned rabbit corneas. Curr Eye Res 1992;11:875-87
31. Cooper DL, Isola NR, Stevenson K, Baptist EW. Members of the ALDH gene family are lens and corneal crystallins. Adv Exp Med Biol 1993;328:169-79
32. Kays WT, Piatigorsky J. Aldehyde dehydrogenase class 3 expression: Identification of a cornea-specific gene promoter in transgenic mice. Proc Natl Acad Sci USA 1997;94:13594-9
33. Sanders EJ. The roles of epithelial-mesenchymal cell interactions in developmental processes. Biochem Cell Biol 1988;66:530-40
34. Martin GR. The roles of FGFs in the early development of vertebrate limbs. Genes Dev 1998;12:1571-86
35. Hay ED, Zuk A. Transformations between epithelium and mesenchyme: normal, pathological, and experimentally induced (Review). Am J Kidney Dis 1995;26:678-90
36. Beebe DC, Coats JM. The lens organizes the anterior segment: specification of neural crest cell differentiation in the avian eye. Dev Biol 2000;220:424-31
37. Hay ED. Development of the vertebrate cornea. Int Rev Cytol 1980;63:263-322
38. Hay ED. An overview of epithelio-mesenchymal transformation. Acta Anat (Basal) 1995;154:8-20
39. Hay ED. Extracellular matrix alters epithelial differentiation (Review). Curr Opin Cell Biol 1993;5:1029-35
40. Hogan BL. Developmental signalling. Sorting out the signals. Curr Biol 1994;4:1122-1124
41. Hogan BL. Morphogenesis. Cell 1999;96:225-33
42. Tripathi BJ, Tripathi RC, Livingston AM, Borisuth NS. The role of growth factors in the embryogenesis and differentiation of the eye. Am J Anat 1991;192:442-71
43. Hauck CR, Hsia DA, Schlaepfer DD. The focal adhesion kinase - a regulator of cell migration and invasion. IUBMB Life 2002;53:115-9
44. Schaller MD. Biochemical signals and biological responses elicited by the focal adhesion kinase. Biochim Biophys Acta 2001;1540:1-21
45. Pfeifer A, Ikawa M, Dayn Y, Verma IM. Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc Natl Acad USA 2002;99:2140-5
46. Rosenbaum JT, Brito B, Han YB,et al. Cytokines. An overview. Adv Exp Med Biol 1998;438:441-6
47. Chakravarti S. The cornea through the eyes of knockout mice. Exp Eye Res 2001;73:411-9
48. Kidson SH, Kume T, Deng K, et al. The forkhead/winged-helix gene, Mf1, is necessary for the normal development of the cornea and formation of the anterior chamber in the mouse eye. Dev Biol 1999;211:306-22
49. Lu MF, Pressman C, Dyer R, et al. Function of Rieger syndrome gene in left-right asymmetry and craniofacial development. Nature 1999;401:276-8
50. Callaerts P, Halder G, Gehring WJ. PAX-6 in development and evolution (Review). Annu Rev Neurosci 1997;20:483-532
51. Hogan BL, Hirst EM, Horsburgh G, Hetherington CM. Small eye (Sey): a mouse model for the genetic analysis of craniofacial abnormalities. Development 1988;103 Suppl:115-9
52. Noll M. Evolution and role of Pax genes (Review). Curr Opin Gen Dev 1993;3:595-605
53. Collinson JM, Hill RE, West JD. Different roles for Pax6 in the optic vesicle and facial epithelium mediate early morphogenesis of the murine eye. Development 2000;127:945-56
54. Gage PJ, Suh H, Camper SA. The bicoid-related Pitx gene family in development. Mamm Genome 1999;10:197-200
55. Arakawa H, Nakamura T, Zhadanov AB, et al. Identification and characterization of the ARP1 gene, a target for the human acute leukemia ALL1 gene. Proc Natl Acad Sci USA 1998;95:4573-8
56. Kitamura K, Miura H, Miyagawa-Tomita S, et al. Mouse Pitx2 deficiency leads to anomalies of the ventral body wall, heart, extra- and periocular mesoderm and right pulmonary isomerism. Development 1999;126:5749-58
57. Semina EV, Reiter R, Leysens NJ, et al. Cloning and characterization of a novel bicoid-related homeobox transcription factor gene, RIEG, involved in Rieger syndrome. Nat Genet 1996;14:392-9
58. Lines MA, Kozlowski K, Walter MA. Molecular genetics of Axenfeld-Rieger malformations. Hum Mol Genet 2002;11:1177-87
59. Hjalt TA, Amendt BA, Murray JC. PITX2 regulates procollagen lysyl hydroxylase (PLOD) gene expression: implications for the pathology of Rieger syndrome. J Cell Biol 2001;152:545-52
60. Kaufmann E, Knochel W. Five years on the wings of fork head. Mech Dev 1996;57:3-20
61. Smith RS, Zabaleta A, Kume T, et al. Haploinsufficiency of the transcription factors FOXC1 and FOXC2 results in aberrant ocular development. Hum Mol Genet 2000;9:1021-32
62. Hong HK, Lass JH, Chakravarti A. Pleiotropic skeletal and ocular phenotypes of the mouse mutation congenital hydrocephalus (ch/Mf1) arise from a winged helix/forkhead transcription factor gene. Hum Mol Genet 1999;8:625-37
63. Pressman CL, Chen H, Johnson RL. LMX1B, a LIM homeodomain class transcription factor, is necessary for normal development of multiple tissues in the anterior segment of the murine eye. Genesis 2000;26:15-25
64. Vollrath D, Jaramillo-Babb VL, Clough MV, et al. Loss-of-function mutations in the LIM-homeodomain gene, LMX1B, in nail- patella syndrome. Hum Mol Genet 1998;7:1091-8
65. McIntosh I, Dreyer SD, Clough MV, et al. Mutation analysis of LMX1B gene in nail-patella syndrome patients. Am J Hum Genet 1998;63:1651-8
66. Lehmann OJ, El-ashry MF, Ebenezer ND, et al. A novel keratocan mutation causing autosomal recessive cornea plana. Invest Ophthalmol Vis Sci 2001;42:3118-22
67. Pellegata NS, Dieguez-Lucena JL, Joensuu T, et al. Mutations in KERA, encoding keratocan, cause cornea plana. Nat Genet 2000;25:91-5
68. Reneker LW, Silversides DW, Xu L, Overbeek PA. Formation of corneal endothelium is essential for anterior segment development - a transgenic mouse model of anterior segment dysgenesis. Development 2000;127:533-42
69. Reneker LW, Silversides DW, Patel K, Overbeek PA. TGF alpha can act as a chemoattractant to perioptic mesenchymal cells in developing mouse eyes. Development 1995;121:1669-80
70. Lovicu FJ, Kao WW, Overbeek PA. Ectopic gland induction by lens-specific expression of keratinocyte growth factor (FGF-7) in transgenic mice. Mech Dev 1999;88:43-53
71. Srinivasan Y, Lovicu FJ, Overbeek PA. Lens-specific expression of transforming growth factor beta1 in transgenic mice causes anterior subcapsular cataracts. J Clin Invest 1998;101:625-34
72. Shull MM, Doetschman T. Transforming growth factor-beta 1 in reproduction and development. Mol Reprod Dev 1994;39:239-46
73. Sanford LP, Ormsby I, Gittenberger-de Groot AC, et al. TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. Development 1997;124:2659-70
74. Proetzel G, Pawlowski SA, Wiles MV, et al. Transforming growth factor-beta 3 is required for secondary palate fusion. Nat Genet 1995;11:409-14
75. Saika S, Saika S, Liu CY, et al. TGFbeta2 in corneal morphogenesis during mouse embryonic development. Dev Biol 2001;240:419-32
76. Luetteke NC, Qiu TH, Peiffer RL, et al. TGF alpha deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice. Cell 1993;73:263-78
77. Berkowitz EA, Seroogy KB, Schroeder JA, et al. Characterization of the mouse transforming growth factor alpha gene: its expression during eyelid development and in waved 1 tissues. Cell Growth Differ 1996;7:1271-82
78. Sibilia M, Wagner EF. Strain-dependent epithelial defects in mice lacking the EGF receptor. Science 1995;269:234-8
79. Yoshida K, Hu Y, Karin M. IkappaB kinase alpha is essential for development of the mammalian cornea and conjunctiva. Invest Ophthalmol Vis Sci 2000;41:3665-9
80. Yujiri T, Ware M, Widmann C, et al. MEK kinase 1 gene disruption alters cell migration and c-Jun NH2-terminal kinase regulation but does not cause a measurable defect in NF-kappa B activation. Proc Natl Acad Sci USA 2000;97:7272-7
81. Leblanc GG, Holbert TE, Darland T. Role of the transforming growth factor-beta family in the expression of cranial neural crest-specific phenotypes. J Neurobiol 1995;26:497-510
82. Vassalli A, Matzuk MM, Gardner HA, et al. Activin/inhibin beta B subunit gene disruption leads to defects in eyelid development and female reproduction. Genes Dev 1994;8:414-27
83. Glise B, Noselli S. Coupling of Jun amino-terminal kinase and Decapentaplegic signaling pathways in Drosophila morphogenesis. Genes Dev 1997;11:1738-47
84. Hou XS, Goldstein ES, Perrimon N. Drosophila Jun relays the Jun amino-terminal kinase signal transduction pathway to the Decapentaplegic signal transduction pathway in regulating epithelial cell sheet movement. Genes Dev 1997;11:1728-37
85. Yang JT, Bader BL, Kreidberg JA, et al. Overlapping and independent functions of fibronectin receptor integrins in early mesodermal development. Dev Biol 1999;215:264-77
86. Yang JT, Hynes RO. Fibronectin receptor functions in embryonic cells deficient in alpha 5 beta 1 integrin can be replaced by alpha V integrins. Mol Biol Cell 1996;7:1737-48
87. Linsenmayer TF, Fitch JM, Birk DE. Heterotypic collagen fibrils and stabilizing collagens. Controlling elements in corneal morphogenesis? (Review). Ann NY Acad Sci 1990;580:143-60
88. Doane XJ, Babiarz JP, Fitch JM, et al. Collagen fibril assembly by corneal fibroblasts in three- dimensional collagen gel cultures: small-diameter heterotypic fibrils are deposited in the absence of keratan sulfate proteoglycan. Exp Cell Res 1992;202:113-24
89. Hahn RA, Birk DE. beta-D xyloside alters dermatan sulfate proteoglycan synthesis and the organization of the developing avian corneal stroma. Development 1992;115:383-93
90. Rada JA, Cornuet PK, Hassell JR. Regulation of corneal collagen fibrillogenesis in vitro by corneal proteoglycan (lumican and decorin) core proteins. Exp Eye Res 1993;56:635-48
91. Gordon MK, Fitch JM, Foley JW, et al. Type XVII collagen (BP 180) in the developing avian cornea. Invest Ophthalmol Vis Sci 1997;38:153-66
92. Muragaki Y, Shiota C, Inoue M, et al. alpha 1(VIII)-collagen gene transcripts encode a short-chain collagen polypeptide and are expressed by various epithelial, endothelial and mesenchymal cells in newborn mouse tissues. Eur J Biochem 1992;207:895-902
93. Nishimura I, Muragaki Y, Hayashi M, et al. Tissue-specific expression of type IX collagen (Review). Ann NY Acad Sci 1990;580:112-9
94. Gordon MK, Foley JW, Lisenmayer TF, Fitch JM. Temporal expression of types XII and XIV collagen mRNA and protein during avian corneal development. Dev Dyn 1996;206:49-58
95. Stock EL, Kurpakus MA, Sambol B, Jones JC. Adhesion complex formation after small keratectomy wounds in the cornea. Invest Ophthalmol Vis Sci 1992;33:304-13
96. Iozzo RV. The biology of the small leucine-rich proteoglycans. Functional network of interactive proteins. J Biol Chem 1999;274:18843-6
97. Iozzo RV. The family of the small leucine-rich proteoglycans: key regulators of matrix assembly and cellular growth. Crit Rev Biochem Mol Biol 1997;32:141-74
98. Williams KJ, Fuki IV. Cell-surface heparan sulfate proteoglycans: dynamic molecules mediating ligand catabolism [see comments] (Review). Curr Opin Lipidol 1997;8:253-62
99. Funderburgh JL. Keratan sulfate: structure, biosynthesis, and function. Glycobiology 2000;10:951-8
100. Scott JE. Proteodermatan and proteokeratan sulfate (decorin, lumican/fibromodulin) proteins are horseshoe shaped. Implications for their interactions with collagen. Biochemistry 1996;35:8795-9
101. Danielson KG, Baribault H, Holmes DF, et al. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 1997;136:729-43
102. Xu T, Bianco P, Fisher LW, et al. Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat Genet 1998;20:78-82
103. Funderburgh JL, Funderburgh ML, Hevelone ND, et al. Sequence, molecular properties, and chromosomal mapping of mouse lumican. Invest Ophthalmol Vis Sci 1995;36:2296-2303
104. Saika S, Shiraishi A, Saika S, et al. Role of lumican in the corneal epithelium during wound healing. J Biol Chem 2000;275:2607-12
105. Chakravarti S, Magnuson T, Lass JH, et al. Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J Cell Biol 1998;141:1277-186
106. Chu PG, Weiss LM. Keratin expression in human tissues and neoplasms. Histopathology 2002;40:403-39
107. Coulombe PA, Omary MB. 'Hard' and 'soft' principles defining the structure, function and regulation of keratin intermediate filaments. Curr Opin Cell Biol 2002;14:110-22
108. Fuchs E, Chan YI, Paller AS, Yu QC. Cracks in the foundation: keratin filaments and genetic disease. Trends Cell Biol 1994;4:321
109. Steinert PM. Structure, function, and dynamics of keratin intermediate filaments (Review). J Invest Dermatol 1993;100:729-34
110. Galvin S, Loomis C, Manabe M, et al. The major pathways of keratinocyte differentiation as defined by keratin expression: an overview (Review). Adv Dermatol 1989;4:277-99; discussion, 300
111. Fuchs E, Coulombe P, Cheng J, et al. Genetic bases of epidermolysis bullosa simplex and epidermolytic hyperkeratosis (Review). J Invest Dermatol 1994;103:25S-30S
112. Chaloin-Dufau C, Sun TT, Dhouailly D. Appearance of the keratin pair K3/K12 during embryonic and adult corneal epithelial differentiation in the chick and in the rabbit. Cell Differ Dev 1990;32:97-108
113. Wu RL, Zhu G, Galvin S, et al. Lineage-specific and differentiation-dependent expression of K12 keratin in rabbit corneal/limbal epithelial cells: cDNA cloning and northern blot analysis. Differentiation 1994;55:137-44
114. Chen WY, Mui MM, Kao WWY, et al. Conjunctival epithelial cells do not transdifferentiate in organotypic cultures: expression of K12 keratin is restricted to corneal epithelium. Curr Eye Res 1994;13:765-78
115. Kolega J, Manabe M, Sun TT. Basement membrane heterogeneity and variation in corneal epithelial differentiation. Differentiation 1989;42:54-63
116. Coulombe PA, Fuchs E. Epidermolysis bullosa simplex (Review). Semin Dermatol 1993;12:173-90
117. Kao WW, Liu CY, Converse RL, et al. Keratin 12-deficient mice have fragile corneal epithelia. Invest Ophthalmol Vis Sci 1996;37:2572-84
118. Corden LD, Swensson O, Swensson B, et al. Molecular genetics of Meesmann's corneal dystrophy: ancestral and novel mutations in keratin 12 (K12) and complete sequence of the human KRT12 gene. Exp Eye Res 2000;70:41-9
119. Irvine AD, Coleman CM, Moore JE, et al. A novel mutation in KRT12 associated with Meesmann's epithelial corneal dystrophy. Br J Ophthalmol 2002;86:729-32
120. Xie W, Chow LT, Paterson AJ, et al. Conditional expression of the ErbB2 oncogene elicits reversible hyperplasia in stratified epithelia and up-regulation of TGFalpha expression in transgenic mice. Oncogene 1999;18:3593-3607
121. Gossen M, Freundlieb S, Bender G, et al. Transcriptional activation by tetracyclines in mammalian cells. Science 1995;268:1766-9
122. Kistner A, Gossen M, Zimmermann F, et al. Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice. Proc Natl Acad Sci USA 1996;93:10933-8
123. Baron U, Gossen M, Bujard H. Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. Nucleic Acids Res 1997;25:2723-9
124. Wang XJ, Greenhalgh DA, Bickenbach JR, et al. Expression of a dominant-negative type II transforming growth factor beta (TGF-beta) receptor in the epidermis of transgenic mice blocks TGF- beta-mediated growth inhibition. Proc Natl Acad Sci USA 1997;94:2386-91
125. Liu X, Alexander V, Vijayachandra K, et al. Conditional epidermal expression of TGFbeta 1 blocks neonatal lethality but causes a reversible hyperplasia and alopecia. Proc Natl Acad Sci USA 2001;98:9139-44
126. Tichelaar JW, Lu W, Whitsett JA. Conditional expression of fibroblast growth factor-7 in the developing and mature lung. J Biol Chem 2000;275:11858-64
127. Araki K, Araki M, Yamamura K. Targeted integration of DNA using mutant lox sites in embryonic stem cells. Nucleic Acids Res 1997;25:868-72
128. Jiang R, Gridley T. Gene targeting: things go better with Cre. Curr Biol 1997;7:R321-R3
129. Michael SK, Brennan J, Robertson EJ. Efficient gene-specific expression of cre recombinase in the mouse embryo by targeted insertion of a novel IRES-Cre cassette into endogenous loci. Mech Dev 1999;85:35-47
130. Gu H, Zou YR, Rajewsky K. Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-loxP-mediated gene targeting. Cell 1993;73:1155-64
131. Ray MK, Fagan SP, Brunicardi FC. The Cre-loxP system: a versatile tool for targeting genes in a cell- and stage-specific manner. Cell Transplant 2000;9:805-15
132. Creancier L, Mercier P, Prats AC, Morello D. c-myc Internal ribosome entry site activity is developmentally controlled and subjected to a strong translational repression in adult transgenic mice. Mol.Cell Biol 2001;21:1833-40
133. Creancier L, Morello D, Mercier P, Prats AC. Fibroblast growth factor 2 internal ribosome entry site (IRES) activity ex vivo and in transgenic mice reveals a stringent tissue-specific regulation. J Cell Biol 2000;150:275-81